After you donate plasma, it goes through a multi-step journey of testing, freezing, processing, and manufacturing before it reaches a patient or pharmacy shelf. The entire process from your arm to a finished medical product typically takes six to twelve months, depending on what the plasma is used for.
Testing and Freezing Within Hours
Your plasma is tested for infectious diseases almost immediately after collection. Screening covers HIV, hepatitis B, hepatitis C, and syphilis, among other pathogens. If any test comes back positive, the donation is discarded and you’re notified. Plasma that passes screening is frozen, usually within 24 hours of collection, and stored at extremely cold temperatures (around -25°C or colder) to preserve the proteins inside it. This frozen state keeps the plasma stable for months while it awaits the next stage.
Donation centers also hold plasma in a quarantine period. Some facilities won’t release a unit until the donor returns for a second donation and passes screening again. This two-donation verification adds another layer of safety, confirming the donor wasn’t in the early window of an infection that the first test might have missed.
Where Your Plasma Goes Next
Donated plasma follows one of two main paths depending on how it was collected and where it was donated. Plasma collected at hospitals and blood banks, often as a byproduct of whole blood donation, is frequently frozen and sent directly to hospitals for transfusion. This is called Fresh Frozen Plasma, and doctors use it to treat patients who are bleeding severely, undergoing major surgery, or have clotting disorders.
Plasma collected at dedicated plasma centers, where donors typically sit for a longer apheresis session, usually heads to a pharmaceutical manufacturer. This is called source plasma, and it makes up the bulk of the global plasma supply. The United States is the world’s largest source of collected plasma, supplying a significant share of the global demand. Most of this source plasma is shipped in frozen form to large-scale fractionation facilities.
How Plasma Is Broken Into Components
Fractionation is the industrial process that separates plasma into its individual therapeutic proteins. The technique most manufacturers use dates back to the 1940s and involves carefully controlled changes in temperature, acidity, and alcohol concentration. Each adjustment causes a different group of proteins to clump together and separate out, much like how different ingredients in a mixture settle at different temperatures.
A single batch of plasma yields several distinct products:
- Immunoglobulins: These are antibodies your immune system produced. Once purified, they’re given to people whose immune systems can’t make enough antibodies on their own, or to patients with certain autoimmune and neurological conditions. Immunoglobulin therapies represent the largest share of plasma-derived products by market demand.
- Clotting factors: Proteins like Factor VIII and Factor IX are essential for blood clotting. Purified clotting factors are a lifeline for people with hemophilia, replacing what their bodies can’t produce.
- Albumin: The most abundant protein in plasma, albumin helps maintain blood volume and pressure. Hospitals use it for burn patients, people in shock, and patients with liver disease.
- Alpha-1 antitrypsin: This protein protects the lungs from damage. People born with a genetic deficiency receive it as an ongoing therapy to slow lung disease progression.
Fractionation facilities process thousands of individual donations in a single batch. Pooling plasma from many donors is necessary to produce enough of each protein, but it also means manufacturers apply multiple viral inactivation steps, including heat treatment and chemical processing, to eliminate any pathogen that screening might have missed.
Manufacturing and Quality Control
After fractionation, each protein product goes through further purification, filtration, and formulation. Manufacturers add stabilizers so the final product can be stored and shipped safely. Every batch undergoes extensive quality testing to confirm it meets standards for purity, potency, and sterility before it’s released.
Regulatory agencies like the FDA in the United States and the European Medicines Agency in Europe oversee the entire chain. They inspect collection centers, review manufacturing processes, and approve each final product. The regulatory requirements are one reason the timeline from donation to finished product stretches so long. Between quarantine holds, shipping, fractionation, purification, quality testing, and regulatory release, a plasma donation made in January might not reach a patient as a finished therapy until the following fall or winter.
How Many Donations It Takes
It takes a surprisingly large volume of plasma to produce a meaningful amount of any single protein. Manufacturing enough immunoglobulin for one patient’s annual treatment can require plasma from over 1,000 individual donations. Albumin production is somewhat more efficient because albumin is so abundant in plasma, but clotting factors and specialty proteins exist in much smaller concentrations, so large pooled volumes are essential.
This is why plasma donation centers allow donors to give much more frequently than whole blood donors. In the U.S., you can donate plasma up to twice per week with at least one day between sessions. Your body replenishes the liquid portion and most proteins within 24 to 48 hours, though immunoglobulin levels can take a bit longer to fully restore.
Plasma That Doesn’t Make It Through
Not every donation reaches a patient. Plasma is discarded if the donor’s screening tests come back reactive, if the sample shows signs of contamination, or if storage conditions were compromised at any point in the cold chain. Units can also be pulled if a donor later reports an illness or medication use that would have made them ineligible at the time of collection. Collection centers track every unit by donor and batch number, so any issue that surfaces after donation can be traced back and affected products can be removed before they’re used.
Some donated plasma is also diverted to research and diagnostic purposes rather than patient therapies. Laboratories use it to develop new tests, calibrate equipment, and study disease markers. While this isn’t the dramatic life-saving use most donors imagine, it supports the broader medical infrastructure that keeps plasma therapies safe and effective.